咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Intravenous proton pump inhibi... 收藏

Intravenous proton pump inhibitors for peptic ulcer bleeding:Clinical benefits and limits

Intravenous proton pump inhibitors for peptic ulcer bleeding:Clinical benefits and limits

作     者:Hsiu-Chi Cheng Bor-Shyang Sheu 

作者机构:Institute of Clinical MedicineMedical CollegeNational Cheng Kung University Department of Internal MedicineNational Cheng Kung University 

出 版 物:《World Journal of Gastrointestinal Endoscopy》 (世界胃肠内镜杂志(英文版)(电子版))

年 卷 期:2011年第3卷第3期

页      面:49-56页

学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主  题:Peptic ulcer bleeding Recurrent bleeding Comorbidity Cytochrome P-450 2C19 Proton pump inhibitor Omeprazole 

摘      要:Peptic ulcer bleeding is a common disease and recurrent bleeding is an independent risk factor of *** with proton pump inhibitors(PPIs) prevents recurrent bleeding after successful endoscopic therapy.A gastric acidic environment of less than pH 5.4 alters coagulation function and activates pepsin to disaggregate platelet *** acid is secreted by H+,K+-ATPase,naming the proton *** update review focuses on the mechanism and the role of PPIs in the clinical management of patients with peptic ulcer *** intravenous omeprazole bolus followed by high-dose continuous infusion for 72 h after successful endoscopic therapy can prevent the recurrent *** the Asian,however,the infusion dosage can possibly be diminished whilst preserving favorable control of the intragastric pH and thereby still decreasing rates of recurrent *** of the infusion dosage of PPIs,rates of recurrent bleeding remain high in patients with *** recurrent peptic ulcer bleeding may be prolonged in those with co-morbidities,a lowdose infusion of IV PPIs for up to 7-day may result in better control of recurrent bleeding of peptic *** to the inter-patient variability in CYP2C19 genotypes,the infusion form of new generation PPIs,such as esomeprazole,should be promising for the prevention of recurrent *** article offers a comprehensive review of clinical practice,highlighting the indication,the optimal dosage,the duration,and the potential limitation of PPIs infusion for peptic ulcer bleeding.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分